The latest quarterly filing of Horizon Space Acquisition II Corp. reveals ongoing deadline extensions and the issuance of unsecured promissory notes reflecting near-term liquidity pressures. The company aims to consummate a two-step merger with SL Bio Ltd. that would transition it into an operating public entity listed on Nasdaq. Horizon Space relies heavily on its management team's network and capital markets experience to source and close this transformative deal. However, challenges persist around timing, financing, regulatory approvals, and post-merger management continuity that will critically shape value creation prospects.